Zobrazeno 1 - 10
of 109
pro vyhledávání: '"Umar, Wazir"'
Autor:
Jajini Varghese, Neill Patani, Umar Wazir, Shonnelly Novintan, Michael J. Michell, Anmol Malhotra, Kinan Mokbel, Kefah Mokbel
Publikováno v:
Cancers, Vol 16, Iss 12, p 2172 (2024)
Recent advances in neoadjuvant systemic therapy (NST) have significantly improved pathologic complete response rates in early breast cancer, challenging the role of axillary lymph node dissection in nose-positive patients. Targeted axillary dissectio
Externí odkaz:
https://doaj.org/article/cbcc1ec37e5f4485b25294a6765555dd
Publikováno v:
Diagnostics, Vol 14, Iss 11, p 1175 (2024)
Targeted axillary dissection (TAD), employing marked lymph node biopsy (MLNB) alongside sentinel lymph node biopsy (SLNB), is increasingly recognised for its efficacy in reducing false negative rates (FNRs) in node-positive early breast cancer patien
Externí odkaz:
https://doaj.org/article/17eb9e182f8841e1a98dd1b3b130c2e5
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 10, p 2908 (2024)
Background/Objectives: De-escalation of axillary surgery is made possible by advancements in both neoadjuvant systemic therapy (NST) and in localisation technology for breast lesions. Magseed®, developed in 2013 by Dr. Michael Douk of Cambridge, Uni
Externí odkaz:
https://doaj.org/article/2887e918168643de99227393b8bc77df
Publikováno v:
Cancers, Vol 16, Iss 7, p 1345 (2024)
SAVI SCOUT® or radar reflector localisation (RRL) has proven accurate in localising non-palpable breast and axillary lesions, with minimal interference with MRI. Targeted axillary dissection (TAD), combining marked lymph node biopsy (MLNB) and senti
Externí odkaz:
https://doaj.org/article/b6a385d45e7e44708b95d5f1e81babed
Publikováno v:
Cancers, Vol 16, Iss 4, p 742 (2024)
Complete axillary lymph node dissection (cALND) was previously the standard of care for breast cancer (BC) patients with axillary node disease or macro-metastases found via sentinel lymph node biopsy (SLNB). However, due to significant morbidity, con
Externí odkaz:
https://doaj.org/article/09306e074033431b9485adebab6b136d
Publikováno v:
Plastic and Reconstructive Surgery, Global Open, Vol 11, Iss 3, p e4860 (2023)
Background:. The treatment of patients requiring explantation of breast prostheses is a complicated clinical issue, for which a consensus regarding the best way forward is still evolving. We believe that simultaneous salvage auto-augmentation (SSAA)
Externí odkaz:
https://doaj.org/article/5349b32b3a524fdea6eba37a1a330c6b
Autor:
Salim Tayeh, Samantha Muktar, Umar Wazir, Amtul. R. Carmichael, Zuhair Al-Fardan, Abdul Kasem, Moustapha Hamdi, Kefah Mokbel
Publikováno v:
Journal of Investigative Surgery, Vol 35, Iss 2, Pp 390-399 (2022)
Background Autologous fat grafting (AFG) is a recognized surgical procedure to correct deformities following breast conservation surgery (BCS) for breast cancer. However, there are concerns about the oncological safety of this technique. In this stud
Externí odkaz:
https://doaj.org/article/237bc1dda7be4e3998927f410c465509
Autor:
Umar Wazir, Kefah Mokbel
Publikováno v:
European Journal of Breast Health, Vol 18, Iss 1, Pp 6-12 (2022)
Breast cancer treatment has seen many advances in recent decades, lessening the morbidity to patients, while improving outcomes. Central to these gains has been the introduction of breast conserving surgery and neoadjuvant systemic therapy (NST). The
Externí odkaz:
https://doaj.org/article/5c65beabc5ad4d9d84dc4ce722e57fa3
Publikováno v:
Cancers, Vol 15, Iss 13, p 3325 (2023)
Recent advances in systemic treatment for breast cancer have been underpinned by recognising and exploiting subtype-specific vulnerabilities to achieve higher rates of pathologic complete response (pCR) after neo-adjuvant systemic therapy (NAST). Thi
Externí odkaz:
https://doaj.org/article/18d56db5b7e74002b1437272c1293e57
Publikováno v:
Cancers, Vol 15, Iss 1, p 13 (2022)
Contrary to traditional assumptions, recent evidence suggests that neoadjuvant systemic therapy (NST) given for invasive breast cancer may eradicate co-existent ductal carcinoma in-situ (DCIS), which may facilitate de-escalation of breast resections.
Externí odkaz:
https://doaj.org/article/b692867ca81b4683bb60e25760eca555